8635

Cyber Savings Season: Get 30% off ACS membership with promo code CYBER24. Offer valid though Dec. 11.

Already an ACS Member? Log in here

Basic

$0 Community Associate

ACS’s Basic Package keeps you connected with C&EN and ACS.

JOIN NOW

Standard

$80 Regular Members & Society Affiliates

ACS’s Standard Package lets you stay up to date with C&EN, stay active in ACS, and save.

Eligibility restrictions apply. Review ACS Membership Packages to see if you qualify.

JOIN NOW

Premium

$160 Regular Members & Society Affiliates
$55 Graduate Students
$25 Undergraduate Students

ACS’s Premium Package gives you full access to C&EN and everything the ACS Community has to offer.

ACS offers discounts for some countries outside the United States. This discount is shown at checkout, if applicable.

JOIN NOW

« Prev

September 1, 2008 Cover

Volume 86, Issue 35

Cystic fibrosis patients could soon benefit from breakthrough small-molecule drugs that treat their underlying disease instead of just their symptoms

Credit:

Full Article

Volume 86 | Issue 35

« Prev

Cystic fibrosis patients could soon benefit from breakthrough small-molecule drugs that treat their underlying disease instead of just their symptoms

Department of Defense memo may reverse the recent rise in government restrictions on some university research

Environment

A Science Sampler From Philly

Highlights include algae biofuel factories, hunting neutrinos, and more
Physical Chemistry

Metal-Organic Liquids Detect Neutrinos
Business

Rewiring Research At Pfizer

Top executives are charged with streamlining an R&D behemoth as they build a biopharma juggernaut
Sign up for C&EN must-read weekly newsletter

Email Address*

Contact us to opt out anytime